COMSTOCK HOLDING COMPANIES (CHCI) Fundamental Analysis & Valuation

NASDAQ:CHCI • US2056842022

Current stock price

15.8 USD
-0.69 (-4.18%)
At close:
15.8 USD
0 (0%)
After Hours:

This CHCI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. CHCI Profitability Analysis

1.1 Basic Checks

  • In the past year CHCI was profitable.
  • CHCI had a positive operating cash flow in the past year.
  • CHCI had positive earnings in each of the past 5 years.
  • CHCI had a positive operating cash flow in each of the past 5 years.
CHCI Yearly Net Income VS EBIT VS OCF VS FCFCHCI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

  • CHCI's Return On Assets of 20.57% is amongst the best of the industry. CHCI outperforms 100.00% of its industry peers.
  • CHCI has a Return On Equity of 24.71%. This is amongst the best in the industry. CHCI outperforms 100.00% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 12.79%, CHCI belongs to the top of the industry, outperforming 98.41% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for CHCI is significantly above the industry average of 5.50%.
  • The 3 year average ROIC (18.89%) for CHCI is well above the current ROIC(12.79%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 20.57%
ROE 24.71%
ROIC 12.79%
ROA(3y)20.05%
ROA(5y)19.74%
ROE(3y)27.08%
ROE(5y)30.75%
ROIC(3y)18.89%
ROIC(5y)16.39%
CHCI Yearly ROA, ROE, ROICCHCI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

1.3 Margins

  • With an excellent Profit Margin value of 24.90%, CHCI belongs to the best of the industry, outperforming 90.48% of the companies in the same industry.
  • CHCI's Profit Margin has improved in the last couple of years.
  • With an excellent Operating Margin value of 16.59%, CHCI belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CHCI has grown nicely.
  • With a Gross Margin value of 21.37%, CHCI perfoms like the industry average, outperforming 46.03% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CHCI has grown nicely.
Industry RankSector Rank
OM 16.59%
PM (TTM) 24.9%
GM 21.37%
OM growth 3Y6.94%
OM growth 5Y17.14%
PM growth 3Y-13.42%
PM growth 5Y51.49%
GM growth 3Y6.26%
GM growth 5Y8.78%
CHCI Yearly Profit, Operating, Gross MarginsCHCI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

9

2. CHCI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CHCI is creating value.
  • The number of shares outstanding for CHCI has been increased compared to 1 year ago.
  • CHCI has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for CHCI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CHCI Yearly Shares OutstandingCHCI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
CHCI Yearly Total Debt VS Total AssetsCHCI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • CHCI has an Altman-Z score of 7.65. This indicates that CHCI is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of CHCI (7.65) is better than 85.71% of its industry peers.
  • There is no outstanding debt for CHCI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 7.65
ROIC/WACC1.42
WACC9.03%
CHCI Yearly LT Debt VS Equity VS FCFCHCI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

  • CHCI has a Current Ratio of 3.95. This indicates that CHCI is financially healthy and has no problem in meeting its short term obligations.
  • CHCI has a better Current ratio (3.95) than 79.37% of its industry peers.
  • CHCI has a Quick Ratio of 3.95. This indicates that CHCI is financially healthy and has no problem in meeting its short term obligations.
  • CHCI has a Quick ratio of 3.95. This is amongst the best in the industry. CHCI outperforms 82.54% of its industry peers.
Industry RankSector Rank
Current Ratio 3.95
Quick Ratio 3.95
CHCI Yearly Current Assets VS Current LiabilitesCHCI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

5

3. CHCI Growth Analysis

3.1 Past

  • CHCI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 123.43%, which is quite impressive.
  • The Earnings Per Share has been growing by 61.08% on average over the past years. This is a very strong growth
  • The Revenue has grown by 22.98% in the past year. This is a very strong growth!
  • The Revenue has been growing by 15.18% on average over the past years. This is quite good.
EPS 1Y (TTM)123.43%
EPS 3Y-1.83%
EPS 5Y61.08%
EPS Q2Q%-77.62%
Revenue 1Y (TTM)22.98%
Revenue growth 3Y18.15%
Revenue growth 5Y15.18%
Sales Q2Q%2.48%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHCI Yearly Revenue VS EstimatesCHCI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

5

4. CHCI Valuation Analysis

4.1 Price/Earnings Ratio

  • CHCI is valuated reasonably with a Price/Earnings ratio of 11.88.
  • CHCI's Price/Earnings ratio is rather cheap when compared to the industry. CHCI is cheaper than 84.13% of the companies in the same industry.
  • CHCI's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.23.
Industry RankSector Rank
PE 11.88
Fwd PE N/A
CHCI Price Earnings VS Forward Price EarningsCHCI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHCI indicates a rather cheap valuation: CHCI is cheaper than 80.95% of the companies listed in the same industry.
  • CHCI's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CHCI is cheaper than 71.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.7
EV/EBITDA 14.64
CHCI Per share dataCHCI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

  • CHCI has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.19
EPS Next 2YN/A
EPS Next 3YN/A

0

5. CHCI Dividend Analysis

5.1 Amount

  • CHCI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CHCI Fundamentals: All Metrics, Ratios and Statistics

COMSTOCK HOLDING COMPANIES

NASDAQ:CHCI (3/20/2026, 8:00:00 PM)

After market: 15.8 0 (0%)

15.8

-0.69 (-4.18%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)03-19
Earnings (Next)05-11
Inst Owners13.15%
Inst Owner Change11.71%
Ins Owners66.06%
Ins Owner Change0.35%
Market Cap159.42M
Revenue(TTM)55.84M
Net Income(TTM)13.90M
Analysts0
Price TargetN/A
Short Float %0.86%
Short Ratio2.08
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 11.88
Fwd PE N/A
P/S 2.86
P/FCF 22.7
P/OCF 21.81
P/B 2.83
P/tB 2.84
EV/EBITDA 14.64
EPS(TTM)1.33
EY8.42%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.7
FCFY4.41%
OCF(TTM)0.72
OCFY4.59%
SpS5.53
BVpS5.58
TBVpS5.56
PEG (NY)N/A
PEG (5Y)0.19
Graham Number12.92
Profitability
Industry RankSector Rank
ROA 20.57%
ROE 24.71%
ROCE 16.19%
ROIC 12.79%
ROICexc 23.58%
ROICexgc 23.74%
OM 16.59%
PM (TTM) 24.9%
GM 21.37%
FCFM 12.58%
ROA(3y)20.05%
ROA(5y)19.74%
ROE(3y)27.08%
ROE(5y)30.75%
ROIC(3y)18.89%
ROIC(5y)16.39%
ROICexc(3y)36.53%
ROICexc(5y)31.24%
ROICexgc(3y)36.83%
ROICexgc(5y)32.34%
ROCE(3y)23.91%
ROCE(5y)20.74%
ROICexgc growth 3Y10.99%
ROICexgc growth 5Y13.58%
ROICexc growth 3Y10.68%
ROICexc growth 5Y17.17%
OM growth 3Y6.94%
OM growth 5Y17.14%
PM growth 3Y-13.42%
PM growth 5Y51.49%
GM growth 3Y6.26%
GM growth 5Y8.78%
F-Score6
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 91.11%
Cap/Sales 0.51%
Interest Coverage 250
Cash Conversion 76.32%
Profit Quality 50.51%
Current Ratio 3.95
Quick Ratio 3.95
Altman-Z 7.65
F-Score6
WACC9.03%
ROIC/WACC1.42
Cap/Depr(3y)179.46%
Cap/Depr(5y)167.67%
Cap/Sales(3y)0.93%
Cap/Sales(5y)0.78%
Profit Quality(3y)87.69%
Profit Quality(5y)95.22%
High Growth Momentum
Growth
EPS 1Y (TTM)123.43%
EPS 3Y-1.83%
EPS 5Y61.08%
EPS Q2Q%-77.62%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.98%
Revenue growth 3Y18.15%
Revenue growth 5Y15.18%
Sales Q2Q%2.48%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.59%
EBIT growth 3Y26.35%
EBIT growth 5Y34.93%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y19.03%
FCF growth 3Y10.69%
FCF growth 5Y4.68%
OCF growth 1Y17.9%
OCF growth 3Y11.03%
OCF growth 5Y4.91%

COMSTOCK HOLDING COMPANIES / CHCI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for COMSTOCK HOLDING COMPANIES?

ChartMill assigns a fundamental rating of 7 / 10 to CHCI.


What is the valuation status of COMSTOCK HOLDING COMPANIES (CHCI) stock?

ChartMill assigns a valuation rating of 5 / 10 to COMSTOCK HOLDING COMPANIES (CHCI). This can be considered as Fairly Valued.


What is the profitability of CHCI stock?

COMSTOCK HOLDING COMPANIES (CHCI) has a profitability rating of 9 / 10.


What are the PE and PB ratios of COMSTOCK HOLDING COMPANIES (CHCI) stock?

The Price/Earnings (PE) ratio for COMSTOCK HOLDING COMPANIES (CHCI) is 11.88 and the Price/Book (PB) ratio is 2.83.


How financially healthy is COMSTOCK HOLDING COMPANIES?

The financial health rating of COMSTOCK HOLDING COMPANIES (CHCI) is 9 / 10.